Respiratory disorders
17 results
Applied filters
Erythromycin for sinusitis
1 October 2026SPS PGD template for the supply of erythromycin for sinusitis in both penicillin allergy and pregnancy, where an intranasal steroid is unsuitable or ineffective
Erythromycin for otitis media
1 October 2026SPS PGD template for the supply of erythromycin for otitis media in both penicillin allergy and pregnancy.
Erythromycin for sore throat
1 October 2026SPS PGD template for the supply of erythromycin for sore throat in both penicillin allergy and pregnancy.
The licence and supporting evidence for omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
Preparing to use omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
Using inhaled or topical corticosteroids during breastfeeding
17 July 2023All topical and inhaled corticosteroids can be used while breastfeeding; there is no preferred choice. Recommendations apply to full term, healthy infants only.